Passive carriage of rabies virus by dendritic cells by unknown
a SpringerOpen Journal
Senba et al. SpringerPlus 2013, 2:419
http://www.springerplus.com/content/2/1/419RESEARCH Open AccessPassive carriage of rabies virus by dendritic cells
Kazuyo Senba1,2, Takashi Matsumoto1, Kentaro Yamada1, Seiji Shiota1, Hidekatsu Iha1, Yukari Date3,
Motoaki Ohtsubo2 and Akira Nishizono1*Abstract
The rabies virus (RABV) is highly neurotropic and it uses evasive strategies to successfully evade the host immune
system. Because rabies is often fatal, understanding the basic processes of the virus-host interactions, particularly in
the initial events of infection, is critical for the design of new therapeutic approaches to target RABV. Here, we
examined the possible role of dendritic cells (DCs) in the transmission of RABV to neural cells at peripheral site of
exposure. Viral replication only occurred at a low level in the DC cell line, JAWS II, after its infection with either
pathogenic RABV (CVS strain) or low-pathogenic RABV (ERA strain), and no progeny viruses were produced in the
culture supernatants. However, both viral genomic RNAs were retained in the long term after infection and
maintained their infectivity. The biggest difference between CVS and ERA was in their ability to induce type I
interferons. Although the ERA-infected JAWS II cells exhibited cytopathic effect and were apparently killed by
normal spleen cells in vitro, the CVS-infected JAWS II cells showed milder cytopathic effect and less lysis when
cocultured with spleen cells. Strongly increased expression of major histocompatibility complex classes I,
costimulatory molecules (CD80 and CD86), type I interferons and Toll- like receptor 3, and was observed only in the
ERA-inoculated JAWS II cells and not in those inoculated with CVS. During the silencing of the cellular immune
response in the DCs, the pathogenic CVS strain cryptically maintained an infectious viral genome and was capable
of transmitting infectious RABV to permissive neural cells. These findings demonstrate that DCs may play a role in
the passive carriage of RABV during natural rabies infections.
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Innate immunity is the first line of defense against invad-
ing pathogens and encompasses several reactions that tar-
get the initial phases of viral infections. Dendritic cells
(DCs) are the most efficient type of antigen-presenting cell
and play a pivotal role in orchestrating both the innate
and adaptive immune responses during viral infections
(Steinman 1991). Upon the uptake of certain viral anti-
gens, DCs undergo maturation, which involves the up-
regulation of surface major histocompatibility complex
(MHC) molecules and the production of type I interferon
(IFN), including IFN-α and –β (Barchet et al. 2002; Cheng
et al. 2004; Dhib-Jalbut and Cowan 1993). During viral
infection, the activation of retinoic-acid-inducible gene I
protein (RIG1), a cellular DExD/H box RNA helicase that
induces the production of antiviral factors, following viral* Correspondence: a24zono@med.oita-u.ac.jp
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in any medium, provided the original work is pRNA detection, leads to increased type I IFN production
(Hornung et al. 2006; Imaizumi et al. 2004; Rothenfusser
et al. 2005; Sakaki et al. 2005). However, several viruses
tend to elicit only weak immune responses or immune re-
sponses that are insufficient to eliminate the invading
pathogen, and it has been suggested that certain RNA vi-
ruses specifically target RIG1 to allow immune evasion
(Leung et al. 2012).
Rabies, although not preeminent among current infec-
tious diseases, continues to afflict humans, with as many
as 55,000 deaths annually. The fatality rate remains the
highest among infectious diseases, and medical treatments
have proven ineffective (Jackson 2013). Rabies virus
(RABV) is a highly neurotropic negative-stranded RNA
virus that spreads along the neural pathway and invades
the central nervous system (CNS), where it causes an acute
and often fatal infection (Finke and Conzelmann 2005).
One of the characteristic features of RABV is its ability to
reach the CNS in spite of inducing an immune response
that can eliminate the virus (Feder et al. 2012). This abilityn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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stages of peripheral infection following an animal bite, the
most common route of transmission, as the virus moves
from the muscle or subcutaneous tissue to the peripheral
neuronal cells. Although reaching the CNS represents a
critical stage in the establishment of the infection, the
pathogenesis and detailed mechanism of host evasion and
the preservation of RABV during these early stages are not
well understood.
Several types of cells directly interact with RABV in the
early stages of infection, at the site of initial exposure. A
recent study has shown that vesicular stomatitis virus,
which belongs to the same genus Rhabdoviridae, gains
access to the CNS through the peripheral nerves in
macrophage-depleted lymph nodes (Iannacone et al.
2010). RABV particles that are injected into the skin or
muscles can slowly replicate in these tissues before they
reach the CNS (Charlton et al. 1997; Murphy et al. 1973).
It is unclear whether RABV directly invades neural cells
or is sequestered by nonpermissive cells that subsequently
migrate to neural cells. Recently, Li et al. demonstrated
that infection with a pathogenic strain of RABV led to
weak DC maturation, whereas a low-pathogenic strain
caused the up-regulation of the NF- κB signaling pathway,
resulting in high levels of IFN-α mRNA in immature DCs
(Li et al. 2008). RABVs are generally classified into two cat-
egories: field-isolated virus (street viruses) and laboratory-
adapted viruses (fixed strains). The former are known to be
more pathogenic after peripheral infections and highly
neuropathogenic. In contrast, the latter generally lose their
infectivity after peripheral inoculation, despite the preser-
vation of their neuropathogenicity (Lepine 1938). Among
the fixed RABVs, representative low-pathogenic strains, in-
cluding Evelyn-Rokitnicki-Abelseth (ERA), Street Alabama
Dufferin and Vnukovo-32, also trigger apoptosis in both
neural and nonneural cells, which acts as a potent activator
of the immune response, leading to the effective eli-
mination of RABV from the CNS (Préhaud et al. 2003;
Thoulouze et al. 1997). In contrast, pathogenic RABV
strains, such as the challenge virus standard (CVS), are
postulated to evade the host immune surveillance system
and to reach neural cells of the CNS by two different
mechanisms (Lafon 2011; Rieder and Conzelmann 2011).
Here, we hypothesize that immature DCs harboring infec-
tious viruses are present for a long time at the site of initial
exposure to RABV. In this study, we sought to clarify the
possible role of RABV-infected DCs at the initial infection
site in the early phase of RABV infection.
Results
Susceptibility of JAWS II cells to RABV
Previous studies have demonstrated that several pathogenic
and non-pathogenic RABV strains can infect immune-
related cells, including T cells and monocytes (Thoulouzeet al. 1997; Nakamichi et al. 2004). Therefore, we examined
whether the DC line, JAWS II, is susceptible to RABV
infection using two types of RABV strains; pathogenic CVS
and low -pathogenic ERA. We first examined whether
RABV can replicate in JAWS II cells and produce progeny
viruses in the culture supernatant. The growth kinetics of
CVS and ERA in NA cells was determined and both RABV
strains replicated significantly at an MOI of 0.1; at 48 h
after infection, their titers were in the range of 106 ~107
ffu/well (Figure 1A). However, both CVS and ERA viral
titers declined rapidly and neither had effectively replicated
in the JAWS II cells at 48 h after infection, even at a high
MOI of 10 or 30 (Figure 1A). Interestingly, infectious
RABV at an MOI of 10 or 30 gradually decreased under
cell-free conditions (CVS or ERA + medium, in Figure 1A)
as a natural result because the virus could not survive with-
out infection into the cells, although a more rapid decline
in infectivity was observed in the presence of JAWS II cells
(CVS or ERA + JAWS II, in Figure 1A), indicating that
RABV was promptly ingested by the cells and that no infec-
tious virus remained in the culture medium.
Because RABV N protein is the most abundantly pro-
duced viral protein in infected cells, we examined the ex-
pression of RABV N protein in the JAWS II cells with
laser scanning microscopy and FACSCalibur flow cytome-
try. Both CVS and ERA effectively propagated in the cells
and strong expression of N protein was observed in the
NA cells with fluorescence-activated cell sorting (FACS)
and immunofluorescence analyses (Figure 1B and C). In
contrast, no fluorescence activity was observed in the
CVS-infected JAWS II cells (Figure 1B and C), and al-
though a mild increase in fluorescence intensity was ob-
served in the ERA-infected JAWS II cells (Figure 1B and
C). Based on these observations, the JAWS II cells were
slightly permissive to ERA infection, but were not suscep-
tible to CVS infection.
Following the experiments described above, in which
the cells were infected with CVS or ERA, we attempted
to detect mRNA and viral genomic RNA in the cells
using RT-PCR at 48, 72, 96, and 120 h after infection.
Low levels of mRNA signals were detected in both the
CVS- and ERA-infected JAWS II cells within 48 h
(Figure 1D). Interestingly, viral genomic RNA was sus-
tainably detected in the JAWS II cells infected with
either CVS or ERA, even after 120 h (Figure 1D).
Cell death of ERA-infected JAWS II cells induced by viral
infection and coculture with spleen cells
Previous studies have demonstrated that low -pathogenic
RABV induces apoptosis in neural and nonneural cells
(Préhaud et al. 2003; Thoulouze et al. 1997). ERA infected
JAWS II cells at 120 h after re-plated to a new plate had
decreased significantly (by nearly 80%), whereas that the
number of CVS-infected JAWS II cells was slightly
Figure 1 Virus growth in JAWS II and NA cells inoculated with rabies virus. (A) Virus growth curves in NA and JAWS II cells. CVS or ERA was
infected at an MOI of 0.1 (NA) or 10,30 (JAWS II), and samples were collected 24 and 48 h after infection. n = 3. Error bars represent mean ± SEM.
The black line and dotted line represent the viral titers of CVS and ERA, respectively. Decline in the infected viral titer was determined by using
JAWS II cells (+JAWS II) and cell-free conditions (+medium). (B and C) The expression of the viral N protein was analyzed with both a laser
scanning microscope and a flow cytometer. After the infection of JAWS II cells with CVS or ERA, the cells were permeabilized with IntraPrep
Permeabilization Reagent, and then incubated with FITC-conjugated anti-RABV N MAb. (D) Detection of mRNA and genomic RNA in CVS- or
ERA-infected JAWS II cells. The upper panel shows GAPDH, the middle panel shows the expression of mRNA from the RABV N gene detected by
RT–PCR, using a poly (T)15 primer for the synthesis of the first-strand cDNA and the lower panel shows viral RNA. The experiments were
performed three times and representative data are shown. CVS or ERA at an MOI of 10 was used for the experiments shown in (B to D).
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showed that the ERA-infected JAWS II cells had a
relatively high cytopathic effect compared with the CVS-
infected JAWS II cells (Figure 2A and B). Using a coculture
assay, we examined whether RABV-infected JAWS II cells
were recognized by and lysed in the presence of spleen
cells. Normal spleen cells cocultured with uninfected
JAWS II cells showed spontaneous cytotoxicity of 36 ±
4.03%. After infection with ERA, JAWS II cells showed bal-
looning, fragmentation, or condensation of their cytoplasm
(Figure 2C and D). The ERA-infected JAWS II cells
showed significantly higher cytotoxicity (92.5 ± 6.02%) than
the CVS-infected JAWS II cells.
Levels of MHC class I and II molecules costimulatory
molecules, innate-immunity-related molecules, and the
production of type I IFNs elevated in ERA-infected
JAWS II cells
To determine whether CVS-infected JAWS II cells can
avoid eliciting host immune responses, we examined the
immune-related surface molecules on JAWS II cells at 48 h
after their infection with CVS or ERA at an MOI of 10.
Because MHC classes I and II are antigen-presenting mole-
cules important in the activation of the immune responses,
their expression on the surfaces of JAWS II cells wasexamined by flow cytometry. The analysis revealed that the
expression of MHC class I increased more strongly on the
surfaces of the cells infected with ERA (Figure 3). Similarly,
the expression of the costimulatory molecules, CD80 and
CD86 was significantly more strongly upregulated in the
ERA-infected JAWS II cells than in the CVS-infected
JAWS II cells.
The phosphoprotein encoded by RABV is known to
possess an antagonizing activity against the induction of
IFN by RIG1 in host cells (Brzózka et al. 2006). Toll-like
receptors (TLRs)-3, -7, -8, and −9 act as sensors of viral
nucleic acids and, with the exception of the TLR-3 signaling
pathway, also induce inflammatory cytokines and IFNs.
Therefore, we also examined how innate immune sensor
molecules are expressed in RABV-inoculated DCs, using
flow cytometry. The expression of TLR-3 was more
strongly elevated in the ERA-infected JAWS II cells than in
the CVS-infected JAWS II cells, when examined flow cy-
tometry (Figure 3). It is well known that the type I IFN re-
sponse controls tissue tropism and pathogenicity during
viral infection processes (Chopy et al. 2011). As well as ana-
lyzing the expression of MHC and costimulatory molecules
after RABV infection, we examined the production of the
type I IFNs, IFN-α and -β, in RABV-infected DCs using
an ELISA. We determined that the production of IFN-α
Figure 2 Morphological changes in JAWS II cells after RABV infection and coculture with mouse spleen cells. (A) Light-microscopic
images of uninfected (left), CVS-infected (middle), and ERA-infected (right) JAWS II cells; (B) the numbers of viable cells were determined by
Trypan blue staining 24, 48, 120 h after re-plated. (C and D) uninfected (left), CVS-infected (middle), and ERA-infected (right) JAWS II cells were
cocultured with mouse spleen cells for a further 120 h and the cytotoxicity was calculated with a cell death kit. All the experiments were
performed three times at an MOI of 10 and representative data are shown (A and C). Error bars represent mean ± SEM (B). *p < 0.01 (D).
Senba et al. SpringerPlus 2013, 2:419 Page 4 of 12
http://www.springerplus.com/content/2/1/419and -β was markedly higher in ERA-infected JAWS II cells
than in cells infected with CVS (Figure 4).
Possible cell-to-cell infection by RABV transmitted from
JAWS II cells to neural cells
To confirm the hypothesis that DCs carry RABV and can
cryptically transmit RABV to neural cells, we performed
in vitro coculture assays to determine whether JAWS IIFigure 3 Expression of cell-surface molecules by flowcytometric analy
the surface molecules on uninfected (control; white), CVS-infected (gray), a
mouse MHC class I, MHC class II and CD80, PE conjugated anti-mouse CD8
conjugated goat anti-rat IgG antibody. The relative fluorescence intensity o
uninfected cells (control) were stained by the same procedure. The experim
*p < 0.001, **p < 0.05, ***p < 0.01.cells harboring the CVS genome facilitate viral transmission
via cell-to-cell infection. Neither productive viral repli-
cation nor viral antigen expression was demonstrated in
the CVS-infected JAWS II cells in the analyses described
above (Figure 1). Although CVS-infected JAWS II cells did
not exhibit progeny viral production when assayed at the
protein or genomic level, they did transmit “infectious viral
genomes” to uninfected “naïve” NA cells, indicating thesis at 48 h after infection of CVS or ERA (MOI of 10). Profiles of
nd ERA-infected (black) JAWS II cells reacted with FITC conjugated anti-
6 and TLR3, and rat anti-mouse RIG1 antibodies, followed by a FITC-
f the surface molecules was determined with FACS. All cells including
ents were performed three times and error bars represent SEM.
Figure 4 Production of IFN-α and IFN-β in CVS- and ERA-inoculated JAWS II cells. (A) The levels of IFN-α (white) and IFN-β (black) in the
culture supernatant 48 h after infection in CVS- or ERA-infected JAWS II cells at various MOIs (0.5, 5, and 10). (B) Serial changes in IFN-α (dotted
line) and IFN-β (black line) production in the CVS-infected (squares) and ERA-infected JAWS II cells (circles) at an MOI of 10. The levels of type I
IFN were quantified by ELISA 72 h after infection. The experiments were performed three times and error bars represent SEM. *p < 0.001, **p < 0.01.
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easily replicated and produced progeny virus in the NA
cells, so the CVS-infected NA cells were capable of trans-
mitting cell-free virus or cell-associated virus (Figure 5).
These results also indicate that the CVS genome was
maintained in the JAWS II cells at detectable levels but
avoided the host immune system, because it did not induce
type I IFNs or upregulate the expression of MHC class I
molecule. However, it retained the ability to infect neuralFigure 5 Cell-to-cell infection of RABV from JAWS II cells to neural ce
JAWS II cells or NA cells (donor cells) was performed as described in the M
scanning microscope. After the infection of JAWS II cells with CVS at an MO
Reagent, and then reacted with FITC-conjugated anti-RABV N MAb. The ex
are shown.cells in vitro through the process of cell-to-cell or “trans”
infection.
Transmission of RABV to mouse brain via JAWS II cells
harboring RABV
To examine whether cell-to-cell transmission occurs
from DCs to neural cells in vivo, we directly examined
the effects of the passive transfer of RABV-infected DCs
to mice. Five-week-old C57BL/6 mice were injectedlls. A coculture assay of NA cells (indicator cells) with CVS-infected
ethods. The expression of the viral N protein was analyzed with a laser
I of 10, the cells were permeabilized with IntraPrep Permeabilization
periments were performed three times and representative data
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infected JAWS II cells (n = 10 each group), and their sur-
vival was monitored for 14 days after transfer. No deaths
were observed in the control group injected with RABV-
uninfected DCs. Mice injected with either CVS- or
ERA-infected JAWS II cells showed clinical symptoms
and finally died in a dose-dependent manner (Figure 6A).
However, the survival of the mice injected with CVS- or
ERA-infected JAWS II cells differed. All mice injected
with 106 CVS-infected JAWS II cells died within 10
days, whereas those injected with 106 ERA-infected
JAWS II cells survived two days longer. Mice injected
with 104 CVS-infected JAWS II cells had a survival rate
of only 20%, whereas 70% survival was observed in mice
injected with same number of ERA-infected JAWS II
cells (Figure 6A). The mice injected with ERA-infected
JAWS II cells showed less lethality and longer survival
than those injected with CVS-infected JAWS II cells,
indicating that ERA-infected JAWS II cells successfully
induced the optimal immune responses required for
viral elimination in vivo (Figure 6A). The surviving mice
showed no apparent neurological manifestations or
sequelae during the observation period. To confirm viral
propagation in the mouse brain, the presence of mRNA
and N protein was examined in the hippocampal tissues
from mice injected with CVS-infected JAWS II cells.
Viral mRNA was clearly detected by RT–PCR and viral
N protein was confirmed with laser scanning microscopy
and an immunochromatographic test (Figure 6B).
Discussion
To examine the potential role of DCs in the transmission
of RABV, we focused on the probable events that occur at
the site of injury caused by rabid animals, by looking into
the migration of RABV toward the CNS, which is the organ
most permissive to RABV. Neither pathogenic CVS nor
low-pathogenic ERA actively produced progeny viruses in
JAWS II cells, which were used in this study. However, viral
genomic RNA lodged persistently inside the virus-infected
cells and was still infectious. Based on our observations,
we propose two possible explanations of how RABV
evades the host’s immune surveillance system and finally
establishes a CNS infection, after which it reaches the brain
cryptically. One possibility is that pathogenic RABV does
not induce effective host responses for viral elimination in
infected DCs; and the other is that the RABV hidden in
these DCs plays a role in its cell-to-cell or trans infection,
thus using DCs as a vehicle in the infection pathway.
In the early phase of the mediation between the innate
and acquired immune responses, DCs predominantly
reside in the peripheral tissues and play a role as sentinel
cells in antigen capture. Immature DCs undergo ma-
turation, characterized by the upregulation of surface
MHC molecules and costimulatory molecules, and thesubsequent release of numerous humoral factors, includ-
ing cytokines and IFNs. Subsequently, the mature DCs
migrate to the peripheral secondary lymphoid tissues,
resulting in the presentation of optimally processed anti-
gen to T lymphocytes via these immune synapses. Our
flowcytometric and ELISA analyses revealed that the
upregulated expression of MHC I molecule on the sur-
face of JAWS II cells and the secretion of type I IFNs
were much greater after they were infected with the
low-pathogenic RABV strain, ERA, than when they were
infected with the pathogenic CVS strain. Analyses of the
surface immune molecules revealed that the JAWS II
cells matured from the immature state after infection
with ERA, but not after infection with CVS.
The mechanism through which JAWS II cells, which
are nonpermissive to RABV, can induce this immu-
nological maturation is explained as follows. The small
amount of N protein produced in the ERA-infected
JAWS II cells (Figure 1B and C) might not be utilized
for viral production or morphogenesis, but may be de-
graded in cellular proteasome and finally assembled with
MHC class I molecules, or the minimal N protein pro-
duced ERA may be presented directly on MHC class I
molecules via a cross-presentation process. Another
possibility is that in response to certain inhibitory mole-
cules (eg. microRNAs) that are only produced during
CVS infection, type I IFNs are not induced in the CVS-
infected JAWS II cells (Zhao et al. 2012).
The inadequate immune response stimulated by CVS
is also supported by the observation that the death of
CVS-infected JAWS II cells was not induced in the pres-
ence of naïve spleen cells, whereas the ERA-infected
cells were successfully lysed. Although we could not
confirm that this was the result of apoptosis, a previous
study has demonstrated that low-pathogenic strains of
RABV can induce apoptotic responses in macrophages
(Jackson and Rossiter 1997). Therefore, it appears that the
pathogenic RABV remains hidden within DCs, where it
effectively evades the host’s immune surveillance system
and may prevent the migration of the infected DCs to the
lymphoid tissues. Since we were not able to detect infec-
tious viruses in supernatants of infected JAWS II cells, it is
also possible that the rate of virus degradation and re-
adsorption is higher than the rate of virus release.
The possibility that RABV exists within DCs below the
detection limit of the immune surveillance system has
important implications for the spread of RABV from the
initial site of infection to the peripheral secondary lymphoid
tissues and neural cells, and for the fate of RABV during
the long-term incubation period that is often observed after
the initial infection (Smith et al. 1991). Although the JAWS
II cells were nonpermissive for RABV replication and could
not produce progeny virus, in vitro coculture studies re-
vealed that NA cells allowed viral transmission after direct
Figure 6 (See legend on next page.)
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Figure 6 Transmission of RABV to mouse brain via JAWS II cells harboring RABV. (A) Survival rates of five-week-old C57BL/6 mice injected
intracerebrally with 106, 105, or 104 CVS- or ERA-infected JAWS II cells (n = 10 each group) at MOI of 30. Their survival was observed for 14 days
after the transfer of the cells. The black and dotted lines represent the survival of the mice injected with CVS- and ERA-infected JAWS II cells,
respectively. The circles indicate the survival of mice injected with 106 CVS- or ERA-infected JAWS II cells. The triangles indicate the survival of
mice injected with 105 CVS- or ERA-infected JAWS II cells. The crosses indicate the survival of mice injected with 104 CVS- or ERA-inoculated JAWS
II cells. The experiments were performed three times. The Kaplan-Meier method was used to analyze mouse survival. Statistical analyses were
performed by log-rank test. (p < 0.01; 106 CVS: 106 ERA, 105 CVS: 105 ERA. p <0.05; 104 CVS: 104 ERA) (B) Half the mice from each group were
sacrificed after seven days, and the presence of viral N mRNA and RABV N protein in the hippocampal tissues was determined by RT–PCR (mRNA)
and a RABV N detection kit with FITC staining, respectively. The arrow indicates the positive band of N protein on the immunochromatographic
test. The upper band corresponds to nonspecific control. The experiments were performed three times as shown in Figure 1B and representative
pictures are shown.
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phenomenon is supported by the fact that the exposure of
CVS- infected JAWS II cells to monoclonal antibodies
directed against a RABV surface glycoprotein (G) 100%
blocked the transmission of RABV to NA (KS and AN, un-
published observation). The relevance of viral transmission
by a cell-to-cell contact process was demonstrated by the
injection of CVS-infected JAWS II cells into the brains of
mice, which led to the rapid spread of the virus and 100%
mortality. In the establishment of immunodeficiency virus
1 (HIV-1) infection, the uptake of HIV-1 by immature DCs
at the mucosal site occurs when it binds to either DC-
SIGN or syndecan-3 (de Witte et al. 2007; Geijtenbeek
et al. 2000). Following the migration of HIV-1 from the ini-
tial mucosal invasion site, DCs may carry the virus to the
draining lymph nodes. It has been demonstrated that dur-
ing the antigen presentation process, DCs cluster with T
cells in the secondary lymphoid tissues (de Witte et al.
2007; Geijtenbeek et al. 2000; Lore and Larsson 2003). It is
well known that abundant nerve-end fibers innervate the
peripheral lymphoid tissue. Other studies have suggested
that prions initially accumulate on follicular dendritic cells
in the lymphoid tissues and subsequently spread via the
peripheral nervous system to the brain (Raymond and
Mabbott 2007; Sethi et al. 2007). Recently, it has been
shown that micro RNAs secreted by Epstein-Barr virus-
infected cells are transferred to uninfected cells via
exosome structures (Pegtel et al. 2010). Our results also
suggest that a mechanism similar to that discussed above
is involved in the transmission of RABV from DCs to CNS.
DCs are heterogeneous cells and comprise several sub-
sets characterized by unique morphological shapes and
functions. Conventional or myeloid-type DCs (mDCs)
have a dendritic shape, exhibit typical DC functions,
such as antigen uptake, processing, and presentation,
and are characterized as CD11c+, CD11b+, and B220-.
In contrast, plasmacytoid DCs, which are nondendritic
round cells, are defined as CD11low, CD11b-, and B220+
cells, and lack the ability to produce costimulatory mole-
cules (Siegemund et al. 2009). Whereas mDC subsets
migrate to the lymph nodes from peripheral tissue,
plasmacytoid DCs directly enter the lymph nodes fromthe blood by crossing high endothelial venules (HEVs)
(Banchereau and Steinman 1998; Shortman and Liu
2002) and are able to transform into mDCs in response
to the surrounding conditions (Fukao et al. 2000; Fukao
et al. 2001; Zuniga et al. 2004). When the cell-surface
markers on JAWS II cells were analyzed by flow cytometry,
CD11c and CD11b were detected, whereas CD8α was not,
and the expression of costimulatory molecules was up-
regulated by stimulation with viral antigens. These results
indicate that JAWS II cells are mDCs, which is consistent
with a previous report (Otsu et al. 2006). It has also been
speculated that the administration of RABV vaccine via an
intradermal route in humans, as well as via the routine
intramuscular route, induce adequate levels of viral neu-
tralizing antibody (Shiota et al. 2008), indicating that mDC
subset are recruited to the vaccination site and migrate to
the lymph nodes for effective antigen presentation to naïve
T cells. Therefore, we speculate that mDCs may play a crit-
ical role in RABV infection and pathogenesis.
Several limitations of our study warrant mention. Our
attempts to determine whether RABV particles could be
visualized in CVS-infected JAWS II cells by immunogold
electron microscopy were unsuccessful. We were also un-
able to confirm the occurrence of apoptosis in the presence
of spleen lymphocytes. However, high level of IFN was
detected, indicating that cellular immunity was fully func-
tional after the infection of JAWS II cells with ERA.
We have provided several lines of evidence that DCs
allow RABV to escape the host immune surveillance sys-
tem and facilitate the transmission of the virus to the
neural cells. Following the uptake of pathogenic CVS, im-
mature DCs do not properly process the viral antigens, as
indicated by their lack of MHC class I and II expression.
Because the RABV genome persists undetected in DCs
and does not replicate or produce progeny virus, we
propose that RABV uses these nonpermissive cells as a
vehicle to reach the peripheral neural cells, where the virus
can then replicate and spread to the CNS. This is the first
report to demonstrate that DCs can transmit RABV to
neural cells by cell-to-cell or trans infection, and sheds
new light on the immune evasion strategies used by this
deadly virus.
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Cells
The DC cell line, JAWS II, and neuroblastoma (NA) cells
were purchased from the American Type Culture Collec-
tion (Manassas, VA). JAWS II cells (CD11b+, CD11c+,
CD8α-, TLR7+, and RIG-1+) were originally isolated from
bone-marrow cultures from p53-deficient C57BL/6 mice.
The cells were grown in a complete culture medium
consisting of RPMI 1640 medium with GlutaMAX™ (Gibco
BRL, Grand Island, NY) and supplemented with 10% fetal
bovine serum (FBS), 1% penicillin-streptomycin, 50 μm
2-mercaptoethanol, and 5 ng/mL recombinant mouse
granulocyte-macrophage colony-stimulating factor (BD
Biosciences, San Jose, CA). Murine NA cells were grown in
Eagle’s minimal essential medium (Gibco BRL, Grand
Island, NY) containing 10% FBS and 1% penicillin-
streptomycin.
Viruses
A pathogenic strain of RABV (CVS-11) and a low- patho-
genic strain (ERA) were propagated in NA cells. The vi-
ruses in the culture supernatants of the RABV-inoculated
NA cells were collected and centrifuged at 1200 × g for 10
min at 4°C (TOMY EX-125, TS-38, TOMY, Tokyo, Japan),
and then purified by ultrafiltration through a 0.45-μm filter.
The infection of NA or JAWS II cells with RABV was
performed at 37°C at various multiplicities of infection
(MOIs).
Antibodies
Fluorescein isothiocyanate (FITC)-conjugated goat anti-
rat IgG antibody was obtained from Organon Teknika
Corp. (Durham, NC). FITC-conjugated anti-mouse MHC
class I, MHC class II, and CD80 antibodies, and phyco-
erythrin (PE)-conjugated anti-mouse CD86 antibody were
purchased from eBioscience Inc. (San Diego, CA). PE-
conjugated anti-mouse CD283 (TLR3) antibody and puri-
fied rat anti RIG1 antibody were obtained from BioLegend
Inc. (San Diego, CA). FITC-conjugated anti-RABV N
monoclonal antibody (MAb) was obtained from Fujirebio
Diagnostics, Inc. (Malvern, PA).
Measurement of viral replication
NA and JAWS II cells were seeded in 48-well culture
plates (105 cells/well) and infected with CVS or ERA at
the appropriate MOI. The culture supernatants obtained
from the RABV-infected NA or JAWS II cells were then
separated by centrifugation at 1200 × g for 10 min 0, 24,
or 48 h after infection. The virions in the supernatant
were purified by ultrafiltration through a 0.45 μm filter
and then titrated. The viruses in the culture superna-
tants were titrated with a focus assay on confluent
monolayers of NA cells in 24-well plates, according to
previously reported procedures (Yamada et al. 2012).Flow cytometry and confocal analysis
The expression of cell-surface molecules was measured
by immunofluorescence flow-cytometric analysis using
a FACSCalibur flow cytometer (BD Immunocytometry
Systems, San Jose, CA) and CellQuest software. For the
analysis, NA and JAWS II cells were first seeded in six-
well culture plates (106 cells/well) and infected with
CVS or ERA at an MOI of 10. After 48 h at 37°C, the
cells were collected and washed in phosphate-buffered
saline (PBS), and then incubated on ice for 30 min
with a FITC-conjugated anti-mouse MHC class I (1:50),
MHC class II (1:50), or CD80 (1:50) antibody, or
PE-conjugated anti-mouse CD86 antibody (1:50). The
expression of the intracellular proteins, TLR-3 and
RIG1 was also measured by immunofluorescence flow-
cytometric analysis using a FACSCalibur flow cytometer
and CellQuest software. After the infection of JAWS II
cells with CVS or ERA (as described above), the cells
were permeabilized with Intra Prep Permeabilization
Reagent (Immunotech, Marseille Cedex, France), according
to the manufacturer’s protocol, and then reacted with
PE-conjugated anti-mouse TLR3 (1:50) or rat anti-
mouse RIG-1 (1:50) antibody. An FITC-conjugated goat
anti-rat IgG (1:200) was used as the secondary antibody
to detected RIG1.
The expression of the viral N protein was analyzed with
both a laser scanning microscope (Carl Zeiss Micro-
Imaging, LSM 510; Carl Zeiss, Jena, Germany) and a
FACSCalibur flow cytometer. After the infection of JAWS
II cells with CVS or ERA (as described above), the cells
were permeabilized with IntraPrep Permeabilization Re-
agent, and then reacted with FITC-conjugated anti-RV N
MAb (1:50).
Enzyme-linked immunosorbent assays (ELISAs)
To measure the quantities of IFN-α and IFN-β secreted by
the RABV-infected JAWS II cells, JAWS II cells seeded in
six-well plates (106 cells/well) were inoculated with CVS or
ERA at an MOI of 10 and the culture supernatants were
then harvested at 0, 12, 24, 48, or 72 h after infection. The
concentrations of IFN-α and IFN-β in the culture superna-
tants were assessed with sandwich ELISA kits (PBL Bio-
medical Laboratories, Piscataway, NJ), according to the
manufacturer’s instructions.
Viral RNA extraction and reverse transcription (RT)-PCR
JAWS II cells in 12-well culture plates (5 × 105 cells/
well) were infected with CVS or ERA at an MOI of 10.
Following incubation for 48, 72, 96, or 120 h, the cells
were collected and washed three times with PBS. The total
RNA was then extracted from the cells using the acid-
guanidinium thiocyanate -phenol -chloroform method
(TRIzol®, Gibco BRL, Gaithersburg, MD). To detect the
viral genomic RNA (negative polarity) or viral mRNA
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fied using the sense primer NF2850 (nucleotides 28–50,
5′-ACAGACAGCGTCAATGGCAGAGC-3′) and anti-
sense primer N660 (R) (nucleotides 660–676, 5′-GTTT
#GGTATAGTACTCC-3′) (Nishizono et al. 2002). The
primer positions are given according to the N gene of
CVS (GenBank accession number DQ286762). Total RNA
(1 μg) was reverse transcribed to synthesize the first-strand
cDNA of the viral genome RNA using the primer N660 (R)
or the viral mRNA using the primer NF2850 and Moloney
murine leukemia virus reverse transcriptase (Gibco BRL) at
37°C for 2 h. The first PCR reaction was performed with
the following reaction mixture: 1 μg of sample cDNA, 50
mM KCl, 10 mM Tris–HCl (pH 8.4), 1.5 mM MgCl2, 20
mM each of primers NF2850 and N660 (R), 200 μM
dNTPs, and 2 U of Taq DNA polymerase (Promega Corp.,
Madison, WI). The reaction mixture was subjected to 35
cycles of denaturation at 95°C for 30 s, annealing at 50°C
for 30 s, and extension at 72°C for 90 s. The resulting
amplicons were resolved electrophoresed on 1% agarose
gels and stained with ethidium bromide. As the internal
control mRNA, glyceraldehyde phosphate dehydrogenase
(GAPDH) transcripts were amplified under the same
conditions, with the sense primer 5′-TTCACCACCATG
GAGAAGGC-3′ and the antisense primer 5′-GGCATG
GACTGTGGTCATGA-3′.
Effect of naïve spleen cells on RABV-infected JAWS II cells
JAWS II cells were seeded in six-well culture plates (106
cells/well) and infected with CVS or ERA at an MOI of 10.
The cells were collected after 48h incubation, washed three
times in PBS, and then plated in a new six-well culture
plate (105 cells/well). Spleen cells were obtained from the
spleens of normal C57BL/6 mice (Otsu et al. 2006) (Charles
River Japan Inc., Yokohama, Japan) and then cultured with
or without the RABV-infected JAWS II cells (106 cells/well;
final E/T ratio = 10:1). After 120 h of coculture, the cells
were observed microscopically (Olympus CK30, Olympus,
Tokyo, Japan) and a cytotoxicity assay was performed with
the Cyto Tox 96® Non-Radioactive Cytotoxicity Assay
(Promega Corp.). Cytotoxicity was calculated according to
the formula: % cytotoxicity = (Experimental LDH release -
Effector Spontaneous LDH release - Target Spontaneous
LDH release / Target Maximum LDH release - Target
Spontaneous LDH release × 100).
Cell-to-cell transmission of RABV from JAWS II cells to
neural cells in vitro
JAWS II cells or NA cells in six-well culture plates (106
cells/well) were infected with CVS at an MOI of 10. After
incubation for 48 h at 37°C, the cells were collected and
washed thoroughly three times with PBS. A virus titration
assay was performed to confirm that there were no
remaining viruses in the supernatant, as described above.The cells were then added to a 24-well plate containing
monolayers of cultured NA cells. After 48 h of coculture,
the NA cells were stained with FITC-conjugated anti-
RABV N protein MAb and observed under a laser scan-
ning microscope.
Injection of CVS- or ERA-inoculated JAWS II cells into
mouse brains
JAWS II cells in six-well culture plates (106 cells/well)
were infected with CVS or ERA at an MOI of 30. Follow-
ing incubation for 48 h, the cells were collected and
washed three times with PBS. A virus titration assay was
performed to confirm that no viruses remained in the
supernatant, as described above. Specific pathogen-free
five-week-old female C57BL/6 mice (Seac Yoshitomi,
Fukuoka, Japan) were injected intracerebrally with 106,
105, or 104 CVS- or ERA-infected JAWS II cells in 0.03
mL with a 23-gauge needle. Half the mice in each injected
group (n = 10) were observed for 2 weeks and their
survival was recorded daily. The remaining mice were
sacrificed on day 7 and the tissue samples taken from the
hippocampus were analyzed for viral N protein using a
laser scanning microscope, for viral mRNA and an
immunochromatographic test that had been developed
previously by us (Nishizono et al. 2008). All animal proce-
dures conformed to animal care guidelines approved by
Ethics Committee in Oita University.
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